
Last updated 2026-08-10 | By Little Words Editorial | How we check our work
Process note: we re-checked every model name, trial fact, and coverage statement on this page against the Lingraphica, ASHA, Medicare, and IDEA pages linked in Sources on August 10, 2026.
Quick answer: Lingraphica makes three dedicated AAC devices, the TouchTalk Plus, TouchTalk, and MiniTalk, all Medicare reimbursable and billed through the company's own funding team. Lingraphica does not publish retail prices; it states many users pay little to nothing after insurance. The lineup and support services center on adults with aphasia, stroke, and brain injury. For a young child, ask your SLP to compare pediatric-first systems before committing.
What is Lingraphica, and who are its AAC devices really for?
Lingraphica is a US company that builds dedicated speech-generating devices and communication apps. Its devices give people with severe speech impairment a touchscreen that speaks selected words and phrases aloud. The American Speech-Language-Hearing Association classifies this kind of tool as aided, high-tech AAC, an area of practice that "supplements or compensates for impairments in speech-language production and/or comprehension." [6]
Lingraphica's catalog and support services are organized around acquired conditions. Its own site lists aphasia, stroke, brain injury, primary progressive aphasia, Parkinson's disease, dysarthria, autism, and apraxia among supported diagnoses, and its community groups are organized by communication diagnosis. [3] In practice the company is best known for adult aphasia support after stroke. That focus is its real strength, and it is also the first thing a parent researching devices for a child should know.
If you are here for a child rather than an adult, skip ahead to the pediatric section below. The short version: Lingraphica can be evaluated for a child, but most families comparing options for a young child will also want pediatric-first systems in the trial, and the decision belongs inside a professional AAC evaluation. [6]
What Lingraphica devices are available in 2026?
Three models, checked on lingraphica.com on August 10, 2026. [1] Earlier Lingraphica hardware went by other names, so older articles and forum posts may mention devices the company no longer sells. Confirm the current lineup directly before any trial.
| Device | Screen | Weight | Battery (stated) | Positioning |
|---|---|---|---|---|
| TouchTalk Plus | 12.4 inch HD display | 1.27 lbs | Up to 6 hours | Largest display, immersive communication and visual support |
| TouchTalk | 10 inch display | 1.12 lbs | Up to 7.5 hours | Mid-size and versatile, billed as its most popular device |
| MiniTalk | 8 inch display | 0.75 lbs | Up to 7 hours | Lightweight design built for life in motion |
All three are dedicated speech-generating devices rather than consumer tablets, which matters for insurance. Medicare covers dedicated SGDs as durable medical equipment; it does not cover ordinary tablets that happen to run a communication app. [4] Lingraphica also ships a conversation aid called Conversations on its devices, which the company describes as letting users review, edit, and speak relevant responses as conversations happen. [3]
How much does a Lingraphica AAC device cost?
Lingraphica does not publish retail prices for the TouchTalk Plus, TouchTalk, or MiniTalk. Here is what the company does say, verbatim from its trial page on August 10, 2026: "Before the trial starts, our funding team reviews your insurance and lets you know about any potential out-of-pocket costs. Many users have little to no cost for the device." [2]
That is a meaningfully different model from list-price shopping, and it cuts both ways. You will not find a sticker price to compare against other brands, but you also will not be asked to buy blind: the insurance review happens before the trial, so you should know your expected cost before committing to anything. Get that expected number in writing, and ask what happens if your insurer denies the claim after the trial.
For context on the funding rails themselves: Medicare recognizes speech-generating devices as durable medical equipment, billed under HCPCS codes in the E2500 to E2599 range. [4] For covered DME, Medicare's own rule is that "after the Part B deductible, you pay 20% of the Medicare-approved amount," with secondary coverage often picking up that remainder. [5] Medicaid and private plans also fund SGDs, with requirements that vary by state and plan. [6]
Which Lingraphica device fits which situation?
The honest decision factors, including the ones a manufacturer page will not lead with:
| Option | Price and funding | Access and eligibility | When not to choose it |
|---|---|---|---|
| TouchTalk Plus | Price not published; billed through insurance via Lingraphica's funding team | Free trial of about three weeks; Medicare DME path requires SLP evaluation, physician visit, and written order | Weight and size are the tradeoff for the 12.4 inch screen; a highly mobile user may prefer smaller |
| TouchTalk | Same funding model as above | Same trial and documentation path | If the user mainly needs a therapy practice app, a free app may be enough to start |
| MiniTalk | Same funding model as above | Same trial and documentation path; lightest option at 0.75 lbs | Smaller screens fit fewer, smaller touch targets; harder for imprecise motor access |
| Pediatric-first alternatives | TouchChat HD $149.99 plus tax; Proloquo2Go $299.99 on iOS (both checked 2026-08-10); dedicated pediatric devices bill through insurance like any SGD | App trials run on hardware you already own; school districts must provide AAC when the IEP team documents the need | Do not pick any brand, including these, without an SLP-led evaluation and device trial |
Every price above was re-verified against the manufacturer's own page on the date shown. Third-party roundups frequently publish stale AAC prices, so treat any undated price, ours included, as a prompt to check the source. [7][8]
Is Lingraphica right for a child?
Usually this question decides itself in the evaluation room, but the background helps. Lingraphica's device pages, community groups, and therapy materials center adult acquired conditions, and the company's public positioning reflects that history. [3] Its site does now list autism and apraxia among supported conditions, so a Lingraphica trial for a child is not out of bounds. [3]
What a parent should actually do: ask the evaluating SLP to name every system being considered and why. Pediatric-focused options with deep vocabulary systems include PRC-Saltillo devices such as the NovaChat, Tobii Dynavox hardware and software (see our Tobii Dynavox guide), and iPad apps like TouchChat and Proloquo2Go. ASHA's position is that SLPs play the central role in AAC screening, assessment, and treatment, and that is doubly true for a developing child. [6]
For school-age children, there is a second funding lane worth knowing: under IDEA regulations, public agencies must make assistive technology available to a child with a disability when the IEP team decides the child needs it for special education, related services, or supplementary aids. [9] That school-provided route is separate from the medical insurance route, and families can pursue both. Our AAC device funding guide walks through the differences.
How do Lingraphica device trials work?
Lingraphica's trial page, checked August 10, 2026, states that "most trials last about three weeks, with regular check-ins from our team to support training, customization, and carryover," and that "device trials are free and have no obligation for purchase." [2] To begin, the company asks for basic contact information, the diagnosis, and insurance details, and its funding review happens before the trial starts. [2]
A practical sequence that protects you:
- Get an AAC evaluation from an SLP, ideally one who works with your family member's diagnosis. Medicare's coverage rules require an SLP evaluation anyway, so this step is not optional for funded devices. [4]
- Ask the SLP which devices to trial, and trial more than one brand when feasible.
- Run the free trial in real settings: home, community, therapy sessions.
- Before accepting a device, get the funding team's out-of-pocket estimate in writing.
- For Medicare, expect the documented path: SLP evaluation, a physician visit, and a written order prior to delivery. [4]
Does Lingraphica have free apps?
Yes. Lingraphica publishes TalkPath Therapy, which its site describes as "free online exercises to practice speech, language, and more," alongside a daily news reading tool. [2] These are practice tools rather than communication devices. The distinction matters for funding: a dedicated SGD can qualify as Medicare DME, while a practice app or a consumer tablet does not. [4]
Used well, a free practice app is a low-risk way to build familiarity while a device evaluation or funding decision is in progress. It supplements therapy; it does not replace an SLP's treatment plan.
Does using an AAC device hold back natural speech?
No. This worry is common and the evidence points the other way. ASHA's AAC Practice Portal states that "AAC use may help improve natural speech when used in a multimodal approach." [6] Clinically, device use and speech goals run side by side: the device carries daily communication while therapy keeps working on speech. If anyone frames it as either-or, ask them for their source.
How does Lingraphica compare to Tobii Dynavox and PRC-Saltillo?
These are the three dedicated-SGD names families hear most. An honest, source-checked comparison:
- Lingraphica: three current devices (TouchTalk Plus, TouchTalk, MiniTalk), free trials of about three weeks, in-house funding team, adult acquired-condition specialty, Medicare reimbursable. [1][2]
- Tobii Dynavox: broad pediatric and adult range, known especially for eye-gaze access hardware. See our full Tobii Dynavox breakdown and, for eye tracking specifically, eye gaze AAC devices.
- PRC-Saltillo: pediatric-strong vocabulary systems on devices like the NovaChat; our PRC devices guide covers the family.
No brand wins on paper. Match the device to the communicator's motor, language, and daily-life profile through trials, and let the SLP document why the winner won; that documentation is also what the funding paperwork needs. [4]
What this page can and cannot tell you
This page can tell you what Lingraphica sells today, how its trial and funding process works, and which questions protect you. It cannot tell you whether a Lingraphica device is right for your family member. That answer requires a hands-on AAC evaluation by a speech-language pathologist, and no article, ours included, substitutes for one. [6]
Little Words builds a speech practice app, not an AAC device, and practice tools of any kind supplement therapy rather than replace it. If your child uses or may use AAC, our guide to how talking practice sits alongside AAC explains where each tool belongs. Broader AAC groundwork lives in our AAC basics hub.
Frequently asked questions
Can a child use a Lingraphica AAC device?
It is possible. Lingraphica lists autism and apraxia among supported conditions, and its historic specialty is adults with aphasia after stroke or brain injury. For a young child, ask the evaluating speech-language pathologist to compare pediatric-focused options such as PRC-Saltillo, Tobii Dynavox, TouchChat, and Proloquo2Go before committing to any brand.
How much does a Lingraphica device cost?
Lingraphica does not publish retail prices for the TouchTalk Plus, TouchTalk, or MiniTalk. Its funding team reviews your insurance before a trial starts and tells you the expected out-of-pocket cost. The company states many users have little to no cost for the device (checked August 10, 2026).
How long is a Lingraphica device trial?
Lingraphica states most device trials last about three weeks, are free, and carry no obligation to purchase. The trial includes regular check-ins for training, customization, and carryover (checked August 10, 2026).
Does Medicare cover Lingraphica devices?
Medicare covers dedicated speech-generating devices as durable medical equipment when coverage criteria are met. The documented path includes a speech-language pathologist evaluation, a physician visit, and a written order before delivery. After the Part B deductible, you pay 20% of the Medicare-approved amount unless secondary coverage picks up the remainder.
Will an AAC device stop someone from working on natural speech?
No. ASHA reports that AAC use may help improve natural speech when used in a multimodal approach. Clinicians run device use and speech goals side by side, so choosing AAC is not choosing against speech.
What is Lingraphica's Conversations tool?
Conversations is a feature on Lingraphica devices aimed at spontaneous conversation. Lingraphica describes it as letting users review, edit, and speak relevant responses as conversations happen (checked August 10, 2026).
Sources
All sources below were opened and checked on August 10, 2026. A quoted passage appears next to each claim it supports.
- Lingraphica, AAC Devices (accessed 2026-08-10): current models TouchTalk Plus (12.4 inch HD display, 1.27 lbs, up to 6 hours), TouchTalk (10 inch, 1.12 lbs, up to 7.5 hours), MiniTalk (8 inch, 0.75 lbs, up to 7 hours).
- Lingraphica, Device Trials (accessed 2026-08-10): most trials last about three weeks; trials are free with no obligation; funding team reviews insurance before the trial; many users have little to no cost; TalkPath Therapy free online exercises.
- Lingraphica, homepage (accessed 2026-08-10): supported conditions listed including aphasia, stroke, brain injury, autism, and apraxia; Conversations tool description; Joint Commission accreditation seal; Medicare Reimbursable badge.
- ASHA, Medicare Coverage Policy on Speech-Generating Devices (accessed 2026-08-10): Medicare recognizes SGDs as durable medical equipment; SLP evaluation required; physician face-to-face visit and written order prior to delivery; HCPCS codes E2500 through E2599; excludes devices useful to someone without a speech impairment.
- Medicare.gov, Durable Medical Equipment coverage (accessed 2026-08-10): after the Part B deductible, you pay 20% of the Medicare-approved amount.
- ASHA, AAC Practice Portal (accessed 2026-08-10): AAC definition; AAC use may help improve natural speech in a multimodal approach; SLPs central to AAC assessment; SGD funding by third-party payers varies.
- PRC-Saltillo, TouchChat HD - AAC (accessed 2026-08-10): price $149.99 USD plus tax.
- AssistiveWare, Proloquo2Go (accessed 2026-08-10): price USD $299.99 on iOS.
- IDEA regulations, 34 CFR 300.105 Assistive technology (accessed 2026-08-10): public agencies must make assistive technology available when required as part of the child's special education, related services, or supplementary aids and services.